PharmaTher Announces Poster Presentation of Positive
Seeking guidance from FDA to proceed towards a Phase 3 clinical study of KETARX™ (ketamine) for Parkinson’s disease under the 505(b)(2) regulatory pathway ...
Source: globenewswire.com
Treating Motor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Treating Motor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Treating Motor Today - Breaking & Trending Today
PharmaTher Announces Late-Breaking Abstract Presentation of
Ketamine was safe, well-tolerated with 100% of patients treated with ketamine demonstrating reduction in dyskinesias as measured by the Unified Dyskinesia...
Source: globenewswire.com
PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson's Disease and Motor Disorders
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Global Digital Therapy Technology Market Report 2021: Opportunities in Healthcare Interoperability for Predictive Digital Care
/PRNewswire/ -- The "Digital Therapy Technology Innovations and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research...
Source: prnewswire.com